While watching late night tv I ran across some numbers we've all been exposed to at one time or another, but which seem to have been strangely, overlooked regarding their potential impact. Monoclonal anti- bodies, administered in one hour infusions, have been found in various studies to be between 70% and as high as 100% effective at keeping covid-19 positive individuals alive and out of hospitals. None the less, these extremely effective and often studied treatments are not universally being used, though they are widely available. A $150,000,000 appropriation in Biden's $1.9 trillion Bill will make them free and widely used. This is great news at one level. But at another, it means that, along with a steady drip of newer covid treatments, the relative value of B for C, even if proved highly effective, will lose some of its luster and value. I'm not saying this to present a negative slant, highly effective results will still be a medical boon and an economic success for IPIX, just less of one than most of us (or at least me) have been expecting. Just sayin'.
Market Data 
Markets 
AI
